Screener
Sabra Healthcare SBRA Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Sabra Healthcare in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Sabra Healthcare’s 10-Q, filed April 29, 2026.
- Filed
- Apr 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001492298-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Repayments of preferred equity investments | 1,256 | 813 |
| Investment in unconsolidated joint ventures | — | (1,030) |
| Insurance proceeds | 107 | — |
| Net cash used in investing activities | (105,090) | (16,444) |
| Cash flows from financing activities: | ||
| Net borrowings from (repayments of) revolving credit facility | 137,800 | (23,881) |
| Principal payments on secured debt | (531) | (517) |
| Payments of deferred financing costs | (92) | (80) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Sabra Healthcare's investing cash flow?
- Sabra Healthcare (SBRA) reported investing cash flow of -$105.09M in Q1 2026.
- How has Sabra Healthcare's investing cash flow changed year-over-year?
- Sabra Healthcare's investing cash flow decreased by 539.1% year-over-year, from -$16.44M to -$105.09M.
- What is the long-term trend for Sabra Healthcare's investing cash flow?
- Over 2 years (2021 to 2025), Sabra Healthcare's investing cash flow has grown at a 6.0% compound annual growth rate (CAGR), from -$336.2M to -$377.96M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Sabra Healthcare's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude